| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd. | Director | Ordinary Shares | 5,729,003 | $44,113,323 | $7.70 | 11 Aug 2025 | Direct |
| Satsuma Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock, $0.0001 par value | 24,847,694 | $22,611,402 | $0.9100 | 06 Jun 2023 | Indirect |
| Wave Life Sciences Ltd. | Director | Share Option (right to buy) | 76,200 | 11 Aug 2025 | Direct | ||
| Satsuma Pharmaceuticals, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 0 | 08 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | 11 Aug 2025 | 2 | $0 | 4 | Director | 13 Aug 2025, 20:00 |
| WVE | Wave Life Sciences Ltd. | 05 Aug 2025 | 1 | -$42,630 | 4 | Director | 07 Aug 2025, 20:00 |
| WVE | Wave Life Sciences Ltd. | 12 Aug 2024 | 2 | $0 | 4 | Director, 10%+ Owner | 14 Aug 2024, 18:00 |
| WVE | Wave Life Sciences Ltd. | 07 Aug 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 09 Aug 2023, 20:00 |
| /report/000089924323014896-takanashi-ken-2023-06-06 | Satsuma Pharmaceuticals, Inc. | 06 Jun 2023 | 4 | +$20,068,759 | 4 | Director, 10%+ Owner | 08 Jun 2023, 16:44 |
| WVE | Wave Life Sciences Ltd. | 15 Aug 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 17 Aug 2022, 20:00 |
| /report/000156761922021461-takanashi-ken-2022-06-03-restatement | Satsuma Pharmaceuticals, Inc. | 03 Jun 2022 | 1 | $0 | 4/A | Director | 09 Dec 2022, 15:11 |
| WVE | Wave Life Sciences Ltd. | 16 Aug 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 18 Aug 2021, 18:11 |